Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1965 1
1968 2
1971 1
1972 3
1973 1
1974 4
1975 1
1976 2
1977 1
1978 3
1979 4
1980 1
1981 1
1982 3
1983 5
1984 6
1985 6
1986 2
1987 9
1988 3
1989 10
1990 10
1991 17
1992 13
1993 23
1994 24
1995 12
1996 23
1997 14
1998 30
1999 48
2000 42
2001 88
2002 98
2003 123
2004 188
2005 209
2006 246
2007 322
2008 369
2009 451
2010 519
2011 578
2012 680
2013 780
2014 791
2015 856
2016 863
2017 840
2018 858
2019 858
2020 879
2021 958
2022 902
2023 838
2024 275

Text availability

Article attribute

Article type

Publication date

Search Results

12,283 results

Results by year

Filters applied: . Clear all
Page 1
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04).
Park S, Kim TM, Han JY, Lee GW, Shim BY, Lee YG, Kim SW, Kim IH, Lee S, Kim YJ, Park JH, Park SG, Lee KH, Kang EJ, Kim JW, Shin SH, Ock CY, Nam BH, Lee J, Jung HA, Sun JM, Lee SH, Ahn JS, Ahn MJ. Park S, et al. Among authors: kim yj. J Clin Oncol. 2024 Apr 10;42(11):1241-1251. doi: 10.1200/JCO.23.01891. Epub 2023 Oct 20. J Clin Oncol. 2024. PMID: 37861993 Clinical Trial.
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.
Park YH, Im SA, Park K, Wen J, Lee KH, Choi YL, Lee WC, Min A, Bonato V, Park S, Ram S, Lee DW, Kim JY, Lee SK, Lee WW, Lee J, Kim M, Kim HS, Weinrich SL, Ryu HS, Kim TY, Dann S, Kim YJ, Fernandez DR, Koh J, Wang S, Park SY, Deng S, Powell E, Ravi RK, Bienkowska J, Rejto PA, Park WY, Kan Z. Park YH, et al. Among authors: kim yj. Genome Med. 2023 Jul 20;15(1):55. doi: 10.1186/s13073-023-01201-7. Genome Med. 2023. PMID: 37475004 Free PMC article.
Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection.
Kim SY, Jeong S, Lee W, Jeon Y, Kim YJ, Park S, Lee D, Go D, Song SH, Lee S, Woo HG, Yoon JK, Park YS, Kim YT, Lee SH, Kim KH, Lim Y, Kim JS, Kim HP, Bang D, Kim TY. Kim SY, et al. Among authors: kim yj. Exp Mol Med. 2023 Nov;55(11):2445-2460. doi: 10.1038/s12276-023-01119-5. Epub 2023 Nov 1. Exp Mol Med. 2023. PMID: 37907748 Free PMC article.
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.
Zanvit P, van Dyk D, Fazenbaker C, McGlinchey K, Luo W, Pezold JM, Meekin J, Chang CY, Carrasco RA, Breen S, Cheung CS, Endlich-Frazier A, Clark B, Chu NJ, Vantellini A, Martin PL, Hoover CE, Riley K, Sweet SM, Chain D, Kim YJ, Tu E, Harder N, Phipps S, Damschroder M, Gilbreth RN, Cobbold M, Moody G, Bosco EE. Zanvit P, et al. Among authors: kim yj. J Clin Invest. 2023 Nov 15;133(22):e169655. doi: 10.1172/JCI169655. J Clin Invest. 2023. PMID: 37966111 Free PMC article.
The Impact of Age on Clinical Outcomes of Acetabular Microfracture During FAI Surgery.
Westermann RW, Nepple JJ, Pascual-Garrido C, Larson CM, Zaltz I, Beaulé PE; ANCHOR Study Group; Kim YJ, Millis M, Sucato DJ, Sink EL, Sierra RJ, Podeszwa DA, Sankar WN, Bedi A, Matheney TH, Novais EN, Belzile EL, Clohisy JC. Westermann RW, et al. Among authors: kim yj. Am J Sports Med. 2023 Aug;51(10):2559-2566. doi: 10.1177/03635465231184398. Epub 2023 Jul 20. Am J Sports Med. 2023. PMID: 37470491
12,283 results
You have reached the last available page of results. Please see the User Guide for more information.